IQVIA™ Real-World Insights Bibliography

Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions?
Author(s): F Christiaan K Dolk, Koen B Pouwels, David R M Smith, Julie V Robotham, Timo Smieszek
Affiliations(s): Public Health England
Publication(s): 
Document Type(s): 
Countries: UK,
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care
Author(s): David R M Smith,F Christiaan K Dolk, Koen B Pouwels, Morag Christie, Julie V Robotham, Timo Smieszek
Affiliations(s): Public Health England
Publication(s): 
Document Type(s): Article,
Countries: England,
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care
Author(s): Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Julie V Robotham, Timo Smieszek
Affiliations(s): Public Health England
Publication(s): 
Document Type(s): Article, Article,
Countries: England,
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Potential for reducing inappropriate antibiotic prescribing in English primary care
Author(s): Timo Smieszek, Koen B Pouwels, F Christiaan K Dolk, David R M Smith, Susan Hopkins, Mike Sharland, Alastair D Hay, Michael V Moore, Julie V Robotham
Affiliations(s): Public Health England
Publication(s): 
Document Type(s): Article,
Countries: England,
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study
Author(s): John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Carter Thorne MD, FRCPC 3, Neil H. Shear MD, FRCPC 4, 5, Gerald Lebovic PhD 6, 7, Sebastien K. Gerega MBA 8, Brad Millson MBS 8, Driss Oraichi PhD 8, Tania Gaetano B.Comm, MIS 9, Sandra Gazel MBA, MSc 9, Martin G. Latour PhD 9, Marie-Claude Laliberté PhD 9
Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Southlake Regional Health Centre, Newmarket, Ontario, Canada 4 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 5 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 6 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 7 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 8 QuintilesIMS, Kirkland, Quebec, Canada 9 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s):  Clinical Therapeutics, Volume 40, Issue 3 pages 415-429.e6
Document Type(s): 
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Observational study, Retrospective cohort analysis,
  Add to report
 
 
Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
Author(s): Louis BessetteEmail author, Gerald Lebovic, Brad Millson, Katia Charland, Krishna Donepudi, Tania Gaetano, Valencia Remple, Martin G. Latour, Sandra Gazel, Marie-Claude Laliberté, Carter Thorne
Affiliations(s): 1. Department of Medicine, Laval University, Quebec, Canada 2. Applied Health Research Centre, St. Michael’s Hospital, Toronto, Canada 3. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada 4. QuintilesIMS, Quebec, Canada 5. AbbVie Corporation, Quebec, Canada 6. Southlake Regional Health Centre, Newmarket, Canada
Publication(s):  Rheumatology and Therapy, June 2018, Volume 5, Issue 1, pages 75-85
Document Type(s): 
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Longitudinal study,
  Add to report
 
 
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study
Author(s):  John K. Marshall MD, MSc, FRCPC 1, Louis Bessette MD, MSc, FRCPC 2, Neil H. Shear MD, FRCPC 3, 4, Gerald Lebovic PhD 5, 6, Jennifer Glass PhD 7, Brad Millson MBS 7, Tania Gaetano BComm, MIS 8, Sandra Gazel MBA, MSc 8, Martin G. Latour PhD 8, Marie-Claude Laliberté PhD 8, J. Carter Thorne MD, FRCP 5, 6
Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 4 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 5 Applied Health Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 QuintilesIMS, Health Access and Outcomes, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s): 
Document Type(s): 
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Longitudinal study, Retrospective cohort analysis,
  Add to report
 
 
pCPA CHANGES AND IMPACT TO MARKET ACCESS IN CANADA: RESULTS FROM AN OBSERVATIONAL CROSS-SECTIONAL STUDY
Author(s): Minhas, Jagdeep, M.Biotech 1; Iqbal-Khan, Sarah, MBA 2; Laforty, Callahan, MSc 2; Millson, Brad, MBS 1
Affiliations(s): 1 1 Health Access and Outcomes, IQVIA, 535 Legget Drive, Kanata, ON, K2K 3B8 2 Health Access and Outcomes, IQVIA, 6755 Century Avenue, Mississauga, ON, L5N 6A4
Publication(s):  2018 CADTH Symposium, April 15-17, 2018, Halifax, NS, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Observational study,
  Add to report
 
 
Translating clinical guidelines into electronic health records criteria to identify patients eligible for treatment
Author(s): Zylbersztejn A, Hardelid P
Affiliations(s): IQVIA/UCL
Publication(s): 
Document Type(s): Oral communication,
Countries: UK,
C:
Y:
Miscellaneous,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Prevalence of Primary Biliary Cholangitis in Canada: First National Study
Author(s): Yoshida EM1, Thiele S2, Fischer A2, Mason A3, Shah H4, Peltekian K5, Hux M2, Borrelli R2
Affiliations(s): 1 Division of Gastroenterology, University of British Columbia 2 QuintilesIMS 3 University of Alberta 4 University of Toronto 5 Dalhousie University
Publication(s):  CANADIAN DIGESTIVE DISEASES 2017 CONFERENCE, MARCH 3-6, BANFF, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Miscellaneous,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
 1 of 21 Next Page Last Page